Olympia Pharmaceuticals

FDA 503B outsourcing facility

Orlando, Florida

TL;DR: Olympia Pharmaceuticals is an FDA-registered 503B outsourcing facility in Orlando, Florida, registered with the FDA since 2014, last inspected August 8, 2025, 94 drug recalls on record.

Key Takeaways

FDA-registered 503B outsourcing facility since 2014
Sterile compounding from bulk substances: Yes
Last FDA inspection: August 8, 2025
94 FDA drug recalls on record (2022)

About this facility

A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.

FDA registration and inspection record

First registered with FDA: March 10, 2014
Most recent registration: November 20, 2025
Compounds sterile drugs from bulk substances: Yes
Last FDA inspection: August 8, 2025

The FDA last inspected Olympia Pharmaceuticals on August 8, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.

FDA recall history

Olympia Pharmaceuticals has 94 FDA drug recalls on record in 2022, based on the FDA enforcement database. Breakdown: 90 Class II, 4 Class III.

Recall reasons on record include lack of assurance of sterility; cgmp deviations: prior to october 1, 2021, environmental and personnel monitoring out of; failed reconstitution time; sub potent; super potent and failed reconstitution time.

Date	Class	Product	Reason
May 2022	Class II	Sodium Bicarbonate 8.4% MDV Injection, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835	Lack of assurance of sterility.
May 2022	Class II	Lidocaine 2% (20 mg/mL), Multi-Dose 30 mL vial , Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-00	Lack of assurance of sterility.
May 2022	Class II	T-106 Papaverine 30 mg/mL Phentolamine 1 mg/mL Alprostadil 25 mcg/mL, Packaged as a) 5 mL Multi-Dose vial NDC 73198-0013-05; b) 10 mL Multi-	Lack of assurance of sterility.
May 2022	Class II	Sodium Selenite 200 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-	Lack of assurance of sterility.
May 2022	Class II	QM-4 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 300 mcg/mL Atropine 0.2 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuti	Lack of assurance of sterility.

Showing the 5 most recent of 94 recall events.

FDA recall classes signal severity, not intent: Class I means a reasonable probability of serious harm, Class II a temporary or reversible risk, Class III a violation unlikely to cause harm. Sterile compounders routinely recall lots as a precaution. FDA definitions.

What this facility compounds

Olympia Pharmaceuticals reports compounding 57 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).

Tracked on PeptideGrids: Glutathione, Liraglutide, Semaglutide, Sermorelin, Tirzepatide.

.alpha.-Lipoic Acid
Acetylcysteine
Alprostadil
Alprostadil; Papaverine Hydrochloride; Phentolamine Mesylate
Arginine Hydrochloride
Ascorbic Acid
Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil
Benzyl Alcohol
Biotin
Calcium Chloride
Calcium Chloride Anhydrous
Cholecalciferol
Choline Chloride; Inositol; Pyridoxine Hydrochloride; Methionine; Thiamine Hydrochloride
Cyanocobalamin
Cyanocobalamin; Pyridoxine Hydrochloride; Choline Chloride; Inositol
Dexpanthenol
Epinephrine; Lidocaine
Glutamine
Glutathione
Glutathione; Ascorbic Acid; Zinc Sulfate Heptahydrate
Glycerin
Glycerin; Lidocaine
Hydroxocobalamin
Inositol; Choline Chloride; Cyanocobalamin; Pyridoxine Hydrochloride; Methionine
Inositol; Choline Chloride; Methionine; Cyanocobalamin
Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride
Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride; Levocarnitine
Levocarnitine
Lidocaine
Lidocaine Hydrochloride

and 27 more.

Location

6700 Conroy Rd Ste 155, Orlando, FL 32835-3515

Satellite and street imagery via Esri. Open larger map.

Contact

FDA-registered contact: Mark Mikhael, 1-407-673-2222. Source: the facility's FDA outsourcing registration.

License verification

503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Olympia Pharmaceuticals with the Florida Board of Pharmacy.

503B facilities in Florida

Florida has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Florida.

Frequently asked questions

Is Olympia Pharmaceuticals registered with the FDA?

Yes. Olympia Pharmaceuticals is a registered 503B outsourcing facility, first registered with the FDA on March 10, 2014 and most recently registered on November 20, 2025.

Has Olympia Pharmaceuticals been inspected by the FDA?

The FDA last inspected Olympia Pharmaceuticals on August 8, 2025. A Form FDA 483 was issued.

Has Olympia Pharmaceuticals had any FDA drug recalls?

Olympia Pharmaceuticals has 94 FDA drug recalls on record (2022) in the FDA enforcement database.

What does Olympia Pharmaceuticals compound?

Olympia Pharmaceuticals reports compounding 57 active ingredients to the FDA, including Glutathione, Liraglutide, Semaglutide, Sermorelin, Tirzepatide.

Where is Olympia Pharmaceuticals located?

Olympia Pharmaceuticals is located in Orlando, Florida (6700 Conroy Rd Ste 155).

Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026. Recall history from the FDA openFDA drug enforcement database, retrieved June 6, 2026.

PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Olympia Pharmaceuticals. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.